ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $93,606,000 | +16.7% | 6,568,851 | -1.8% | 0.59% | +14.2% |
Q2 2018 | $80,242,000 | -6.7% | 6,686,811 | -4.0% | 0.51% | -2.7% |
Q1 2018 | $86,050,000 | -11.9% | 6,967,591 | +3.8% | 0.53% | -12.2% |
Q4 2017 | $97,705,000 | +13.5% | 6,715,086 | +11.0% | 0.60% | +17.9% |
Q3 2017 | $86,051,000 | +10.9% | 6,047,181 | -0.6% | 0.51% | +9.2% |
Q2 2017 | $77,626,000 | +1.3% | 6,083,536 | +0.6% | 0.47% | +5.0% |
Q1 2017 | $76,652,000 | +59.6% | 6,045,110 | +28.5% | 0.44% | +51.0% |
Q4 2016 | $48,020,000 | -7.9% | 4,703,240 | +18.8% | 0.29% | -10.1% |
Q3 2016 | $52,152,000 | +0.1% | 3,959,900 | -3.4% | 0.33% | +3.2% |
Q2 2016 | $52,084,000 | +21.1% | 4,101,075 | +26.0% | 0.32% | +25.3% |
Q1 2016 | $42,992,000 | +5.6% | 3,254,475 | +22.9% | 0.25% | +9.1% |
Q4 2015 | $40,716,000 | +21.8% | 2,647,348 | -1.8% | 0.23% | +25.4% |
Q3 2015 | $33,427,000 | -9.0% | 2,695,705 | +0.4% | 0.18% | -3.1% |
Q2 2015 | $36,725,000 | +14.9% | 2,684,592 | +0.5% | 0.19% | +15.1% |
Q1 2015 | $31,957,000 | – | 2,672,015 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |